ICU-acquired weakness (ICUAW) defines a heterogeneous group of critically ill patients with hospital-acquired impairment in physical function. ICUAW is defined as a Medical Research Council (MRC) score below 48, or an average muscle strength of less than four out of five in six specified bilateral muscle groups. By definition, critical care patients with MRC scores of at least 48 are considered to not have ICUAW. However, many of these patients may have generalized impairment in muscle strength and function. In critical care patients that do not develop formal criteria for ICUAW, abnormalities on electrophysiological testing may help identify physical impairments and determine the etiology of this weakness. We hypothesized that a subset of critically ill patients without ICUAW have abnormal nerve conduction study (NCS) amplitudes that are associated with reduced physical function.
Our institutional review board approved the study. Using data from a prior prospective ICU study of neuromuscular function [1], patients with the following characteristics were included: a diagnosis of sepsis and/ or acute respiratory failure, and no ICUAW defined as an MRC score of at least 48 (highest score is 60). Each week until ICU discharge, a neurologist performed NCS of six nerves of the upper and lower extremities. Each week until hospital discharge, a physical therapist (blinded to the results of NCS) administered the functional independence measurement (FIM) scale that categorizes physical impairment and need for assistance to perform activities of daily living (ADLs) [2] . The physical therapist obtained three components of the FIM scale, specifically bed mobility, transfers, and gait. Each component is scaled from 0 to 7, with higher scores indicating less assistance needed to perform the task. We determined differences in the last recorded FIM scores prior to hospital discharge between critically ill patients with and without two individual NCS amplitudes below the outpatient lower limit of normal. We selected abnormalities in NCS amplitudes for two nerves as a criterion because abnormalities in one nerve could be the result of an undiagnosed pre-existing focal unilateral neuropathy.
The study cohort comprised 22 patients (median age 52 years, 68 % male, median MRC score 59/60, median admission APACHE II score 18.5), of whom 13 had at least two individual NCS amplitudes below the outpatient lower limit of normal (Supplementary Table 1 ). On the last testing before hospital discharge, patients with abnormal NCS amplitudes had lower FIM scores on the physical function tests of bed mobility (p = 0.04), transfers (p = 0.02), and gait (p = 0.01) compared to patients without electrophysiological abnormalities (Table 1) . Seventeen patients had peroneal nerve testing, which has been examined as a screen for critical illness polyneuromyopathy in patients with ICUAW [1, 3] . Patients with at least one peroneal nerve amplitude below the outpatient lower limit of normal had lower FIM scores on all Table 2 ).
This study is the first to demonstrate that a subset of critically ill patients without ICUAW have abnormal NCS amplitudes and associated functional limitations. On the basis of median FIM scores, patients with abnormal NCS amplitudes would still require in-person assistance to perform ADLs after hospital discharge, whereas patients without electrophysiological abnormalities would be completely independent. Functional status is an important outcome, since critical care survivors with lower FIM scores on bed mobility, transfers, and gait at hospital discharge have increased 90-day post-hospital discharge all-cause mortality [4] . Functional limitations are also a possible explanation for the recent results of Hermans et al. showing that abnormal electrophysiology is associated with increased 1-year mortality, even in patients with normal strength [5] . The arbitrary selection of an MRC score below 48 as defining ICUAW likely misses an important group of patients with normal-range strength but abnormal electrophysiology and functional limitations. Increasing the use of electrophysiological testing may assist with the diagnosis of neuromuscular disorders and improve ability to render a prognosis for critically ill patients without ICUAW.
